Edge Wealth Management LLC Aveo Pharmaceuticals, Inc. Transaction History

Edge Wealth Management LLC

  • $497 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022
SELL
$3.15 - $6.01 $3,150 - $6,010
-1,000 Closed
0 $0
Q4 2021

Jan 21, 2022
BUY
$4.69 - $7.4 $4,624 - $7,296
986 Added 7042.86%
1,000 $5,000
Q4 2021

Jan 14, 2022
SELL
$4.69 - $7.4 $4,624 - $7,296
-986 Reduced 98.6%
14 $5,000
Q1 2020

Apr 20, 2020
BUY
$2.6 - $6.9 $2,600 - $6,900
1,000 New
1,000 $4,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email